Clorox Plunges 6% After-Hours as Slashed Outlook Overshadows Earnings Beat

Guidance Cut Rattles Investors in Extended Trading

Clorox shares took a sharp hit after the close on Thursday, falling 5.84% to trade near 52-week lows. The move came immediately following the release of the company's fiscal third-quarter results. While Clorox reported adjusted earnings per share (EPS) of $1.64, beating the analyst consensus of $1.53, the victory was short-lived as management issued a drastic downward revision to its full-year 2026 outlook.

The company now expects full-year adjusted EPS to fall between $5.45 and $5.65, a significant drop from previous expectations and well below the Wall Street consensus of $5.86. At the midpoint, this represents a nearly 10% shortfall compared to analyst projections. Furthermore, Clorox warned that net sales for the fiscal year are expected to decline by approximately 6%, with organic sales projected to slide as much as 9%.

Margin Pressures and Cost Headwinds

A primary driver of the after-hours rout was the company's deteriorating margin profile. Clorox updated its full-year gross margin outlook to a decline of 250 to 300 basis points, a sharp reversal from its prior forecast of a more modest 50 to 100 basis point contraction. Management cited persistent headwinds from higher manufacturing and logistics costs, alongside an unfavorable product mix that has hampered profitability.

CEO Linda Rendle described the quarter as "mixed," noting that while some parts of the portfolio showed momentum, market share recovery in other areas has been slower than anticipated. The company is also grappling with the unwinding of shipment impacts from a previous ERP transition, which is expected to account for a substantial 7.5-point decrease in reported sales as retailer inventory levels normalize.

Strategic Shifts and Sector Context

The volatility comes as Clorox undergoes a significant portfolio reshaping. The company recently completed its $2.25 billion acquisition of GOJO Industries, the maker of Purell, on April 1, 2026. While the deal is expected to contribute roughly 3 percentage points to net sales, the integration and transaction-related costs are weighing on the immediate bottom line.

Clorox's nearly 6% plunge stands in stark contrast to the broader market, with the S&P 500 (SPY) remaining flat in the after-hours session. This massive divergence highlights the stock-specific distress as investors re-evaluate the company's growth trajectory in a "challenging consumer and cost environment." With a heavy volume of 4.6 million shares traded in the extended session, the move suggests a significant institutional repositioning as the market digests the lowered bar for the remainder of the fiscal year.